Laboratory Equipment Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The laboratory equipment market covers analytical instruments, general-purpose lab devices, specialty equipment, and related services and consumables used in scientific and industrial settings. Published valuations for 2025 range from roughly USD 16 billion to over USD 43 billion, reflecting differences in scope between equipment-only, equipment-plus-services, and equipment-plus-disposables definitions. Independent industry estimates generally cluster near the USD 30 billion mark for 2025, supporting the headline figure used here. The market serves pharmaceutical and biotechnology companies, academic and government research institutes, hospitals and diagnostic laboratories, and industrial quality-control facilities.

• •Estimated global value of approximately USD 30.08 billion in 2025.
• •Forecast CAGR of 9.68% positions the market for sustained double-digit-style expansion over the forecast window.
• •End-users span pharmaceutical, biotechnology, academic, clinical diagnostic, food and beverage, environmental, and chemical industries.

Sustained growth is being driven by rising global investment in pharmaceutical and biotechnology research, including the development of biologics, cell and gene therapies, and personalized medicines. Public and private funding for academic and clinical research, along with the expansion of contract research and contract manufacturing organizations, is generating steady demand for new instruments and service contracts. Regulatory pressure for higher-quality data, combined with workforce shortages in skilled laboratory personnel, is encouraging laboratories to adopt more automated and digitally connected equipment.

• •Increasing R&D expenditure across the pharmaceutical and biotechnology sectors is expanding instrument procurement budgets.
• •Growing outsourcing of research and testing to CROs and CDMOs is supporting multi-year equipment and service contracts.
• •Demand for higher throughput, reproducibility, and compliance is accelerating the shift to automated and digitally integrated lab systems.

The market is typically segmented by product type into analytical instruments (such as spectroscopy, chromatography, and microscopy systems), general lab equipment (centrifuges, incubators, autoclaves, and balances), specialty equipment, and laboratory services and consumables. By end-user, the largest share is held by pharmaceutical and biotechnology companies, followed by academic and government research institutes, hospitals and diagnostic labs, and industrial users. North America accounts for the largest share of revenue, supported by a dense base of pharmaceutical companies, research institutes, and advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region as China, India, Japan, and South Korea expand their life sciences capabilities.

• •Analytical instruments and general lab equipment together represent the largest product categories by revenue.
• •Pharmaceutical and biotechnology companies are the leading end-user segment, with academic and clinical diagnostics as major secondary segments.
• •North America leads in revenue share, while Asia-Pacific is the fastest-growing regional market due to expanding R&D investment.

What are the recent trends and outlook?

Key trends shaping the market include the integration of artificial intelligence and machine learning into instrument software, the rise of cloud-connected and remotely monitored laboratory equipment, and the development of more energy-efficient and sustainable lab products. Laboratories are also moving toward modular and scalable platforms that can be reconfigured as research priorities change. Looking ahead, the market is expected to continue expanding at a high single-digit to low double-digit CAGR through the early 2030s, with the strongest gains likely in Asia-Pacific and in product categories tied to biologics development, advanced diagnostics, and automated sample preparation.

• •AI-enabled analytics, cloud connectivity, and digital lab platforms are emerging as key differentiators among equipment vendors.
• •Demand for sustainable, energy-efficient, and modular laboratory equipment is rising as labs modernize their facilities.
• •Long-term growth is expected to be strongest in Asia-Pacific and in equipment supporting biologics, cell and gene therapy, and advanced diagnostics workflows.